Analysis of the GSE4170 data set revealed that WEE1 expression was upregulated in patients with CML BP, suggesting a potential role for WEE1 in disease progression (Figure 1c). This evidence concerns the gene WEE1 and chronic myelogenous leukemia, BCR-ABL1 positive.